132 related articles for article (PubMed ID: 37609670)
1. Outcomes of lung oligometastasis in pancreatic cancer.
Takeda T; Sasaki T; Ichinose J; Inoue Y; Okamoto T; Mie T; Furukawa T; Kasuga A; Oba A; Matsuura Y; Nakao M; Ozaka M; Mun M; Takahashi Y; Sasahira N
Jpn J Clin Oncol; 2023 Dec; 53(12):1144-1152. PubMed ID: 37609670
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of pancreatic cancer with liver oligometastasis.
Takeda T; Sasaki T; Okamoto T; Kasuga A; Matsuyama M; Ozaka M; Inoue Y; Takahashi Y; Saiura A; Sasahira N
J Hepatobiliary Pancreat Sci; 2023 Feb; 30(2):229-239. PubMed ID: 35593731
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
4. Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma.
Albergotti WG; Abberbock S; Mathews F; Ferris RL; Johnson JT; Duvvuri U; Kim S
Head Neck; 2018 Aug; 40(8):1685-1690. PubMed ID: 29756301
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes for oligometastasis in resected non-small cell lung cancer.
Shimada Y; Saji H; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):937-44. PubMed ID: 26207006
[TBL] [Abstract][Full Text] [Related]
6. Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review.
Liu Q; Zhang R; Michalski CW; Liu B; Liao Q; Kleeff J
Sci Rep; 2020 Mar; 10(1):4444. PubMed ID: 32157155
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and Prognostic Analysis of Surgical Resection for Oligometastasis from Hepatocellular Carcinoma.
Oshita KO; Kobayashi T; Tadokoro T; Namba Y; Fukuhara S; Matsubara K; Takei D; Honmyo N; Kuroda S; Kawaoka T; Aikata H; Ohdan H
Anticancer Res; 2023 Nov; 43(11):5189-5196. PubMed ID: 37909959
[TBL] [Abstract][Full Text] [Related]
8. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
[TBL] [Abstract][Full Text] [Related]
9. [Treatments for Pancreatic Cancer with Oligometastasis].
Furuse J
Gan To Kagaku Ryoho; 2017 Oct; 44(10):827-830. PubMed ID: 29066673
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
12. Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma.
Berzenji D; Sewnaik A; Keereweer S; Monserez DA; Verduijn GM; van Meerten E; Mast H; Mureau MAM; van der Lugt A; Koljenovic S; Dronkers EAC; Baatenburg de Jong RJ; Hardillo JA
Oral Oncol; 2021 Aug; 119():105356. PubMed ID: 34034098
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.
Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN
Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524
[TBL] [Abstract][Full Text] [Related]
14. Current status of pancreatic cancer with oligometastasis.
Chapa-Azuela Ó; Corona-Torres MJ; Ayala-Moreno EA; Arroyo-Paredes PS; Pérez-Torres E; Rodríguez-Báez A; Montalvo-Javé EE
Cir Cir; 2023; 91(2):262-267. PubMed ID: 37084317
[TBL] [Abstract][Full Text] [Related]
15. Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
Shirasawa M; Fukui T; Kusuhara S; Harada S; Nishinarita N; Hiyoshi Y; Ishihara M; Kasajima M; Igawa S; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Naoki K
PLoS One; 2019; 14(4):e0214599. PubMed ID: 31002722
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature.
Sakaguchi T; Valente R; Tanaka K; Satoi S; Del Chiaro M
Pancreatology; 2019 Jul; 19(5):672-680. PubMed ID: 31285145
[TBL] [Abstract][Full Text] [Related]
17. Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study.
Satoi S; Yamamoto T; Hashimoto D; Yamaki S; Matsui Y; Ikeura T; Boku S; Shibata N; Tsybulskyi D; Sekimoto M
J Gastrointest Oncol; 2023 Dec; 14(6):2587-2599. PubMed ID: 38196535
[TBL] [Abstract][Full Text] [Related]
18. Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer.
Terao T; Kumagi T; Hyodo I; Yokota T; Azemoto N; Miyata H; Kuroda T; Ohno Y; Tanaka Y; Shibata N; Imamura Y; Kanemitsu K; Miyake T; Koizumi M; Hiasa Y;
Medicine (Baltimore); 2021 Oct; 100(43):e27591. PubMed ID: 34713835
[TBL] [Abstract][Full Text] [Related]
19. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1).
Wei M; Shi S; Hua J; Xu J; Yu X;
BMJ Open; 2019 Dec; 9(12):e033452. PubMed ID: 31818843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
